Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$696,131
-$33,033 QoQ
Shares Held
2,741
-8.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3,359
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOOMIS SAYLES & CO L P holds $1,754,958,212 across 10 Drug Manufacturers - General names. JNJ ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
18,594,352 | $891,413,233 | |
| 2 | NVS |
Novartis AG
|
5,239,309 | $821,104,505 | |
| 3 | ABBV |
AbbVie Inc.
|
43,544 | $10,957,411 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
170,634 | $9,831,930 | |
| 5 | MRK |
Merck & Co., Inc.
|
58,514 | $7,519,048 | |
| 6 | LLY |
ELI LILLY & Co
|
5,956 | $7,143,805 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
46,442 | $5,867,481 | |
| 8 | JNJ |
Johnson & Johnson
This page
|
2,741 | $696,131 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $696,131 | 2,741 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $729,164 | 2,983 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,885,279 | 18,774 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $6,888,723 | 37,152 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $11,652,227 | 76,283 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $8,030,138 | 48,421 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $11,799,978 | 81,593 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $14,198,238 | 87,611 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $8,878,050 | 60,742 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,824,470 | 55,784 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,998,596 | 38,271 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,241,228 | 27,231 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $4,894,095 | 29,568 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,969,420 | 44,964 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,990,409 | 45,233 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $7,546,250 | 46,194 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $31,966,710 | 180,084 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $52,177,398 | 294,405 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $44,195,249 | 258,346 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $48,911,728 | 302,859 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $47,316,457 | 287,219 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $51,256,162 | 311,872 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $16,755,776 | 106,467 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,219,354 | 14,907 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,125,762 | 15,116 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,102,275 | 16,032 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||